Cancer (Oncology)

Afanat 40® Afatinib Tablets
Afatinib Dimaleate 40mg
- Composition
- Afatinib Dimaleate 40mg
- Dosage form
- Tablet
- Pack size
- Bottle of 28 Tablet
- Manufacturer
- Natco
- Also known as
- Gilotrif, Giotrif, Xovoltib
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Afanat 40 mg contains afatinib, a targeted therapy used to treat specific forms of advanced non-small cell lung cancer, particularly tumours with certain EGFR mutations. It blocks signalling pathways involved in cancer cell growth
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
